×
Surgery Partners Net Profit Margin 2013-2025 | SGRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Surgery Partners net profit margin from 2013 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Surgery Partners Net Profit Margin 2013-2025 | SGRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Surgery Partners net profit margin from 2013 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$146.1B
CVS Health (CVS)
$78.8B
Elevance Health (ELV)
$66.1B
Cencora (COR)
$56.6B
DiDi Global (DIDIY)
$24.2B
Labcorp Holdings (LH)
$22.1B
Natera (NTRA)
$19.2B
BioMerieux (BMXMF)
$17.1B
EUROFINS SCIENT (ERFSF)
$14.9B
ICON (ICLR)
$14.7B
CochLear (CHEOY)
$13.3B
Solventum (SOLV)
$12.6B
Medpace Holdings (MEDP)
$12.3B
Revvity (RVTY)
$10.7B
Viatris (VTRS)
$10.6B
Avantor (AVTR)
$9.4B
Sonic Healthcare (SKHHY)
$8.9B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.5B
Caris Life Sciences,�Inc (CAI)
$7.5B
Bausch + Lomb (BLCO)
$4.9B
Amplifon S.p.A (AMFPF)
$3.9B
BrightSpring Health Services (BTSG)
$3.7B
Sotera Health (SHC)
$3.4B
GeneDx Holdings (WGS)
$3B
Concentras Parent (CON)
$2.6B
Organon (OGN)
$2.6B
Alignment Healthcare (ALHC)
$2.6B
Progyny (PGNY)
$2B
Premier (PINC)
$1.8B